We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Amdocs
DOX
$5.92B
| $16.4M | 0.04% |
268,586
+74,263
| +38% | +$4.46M |
|
477
Trimble
TRMB
$13.2B
| $16.3M | 0.04% |
510,460
+15,694
| +3% | +$485K |
|
478
Annaly Capital Management
NLY
$17.1B
| $16.3M | 0.04% |
367,532
+16,540
| +5% | +$704K |
|
479
BorgWarner
BWA
$13.1B
| $16.2M | 0.04% |
440,499
+14,725
| +3% | +$537K |
|
|
WR
480
DELISTED
Westar Energy Inc
WR
| $16.2M | 0.04% |
297,619
+10,844
| +4% | +$590K |
|
481
Acuity Brands
AYI
$9.83B
| $16M | 0.04% |
78,646
+1,929
| +3% | +$407K |
|
482
Camden Property Trust
CPT
$11B
| $16M | 0.04% |
198,842
+29,108
| +17% | +$2.4M |
|
|
SEE
483
DELISTED
Sealed Air
SEE
| $15.9M | 0.04% |
365,974
-3,593
| -1% | -$169K |
|
484
Qorvo
QRVO
$7.99B
| $15.8M | 0.04% |
230,772
+11,329
| +5% | +$728K |
|
485
Bunge Global
BG
$20.4B
| $15.7M | 0.04% |
197,756
-1,240
| -0.6% | -$92.9K |
|
486
Ashland
ASH
$3.33B
| $15.6M | 0.04% |
257,356
+8,438
| +3% | +$489K |
|
487
Raymond James Financial
RJF
$33.8B
| $15.6M | 0.04% |
306,429
-51,245
| -14% | -$2.61M |
|
488
Factset
FDS
$9.36B
| $15.6M | 0.04% |
94,386
+4,803
| +5% | +$840K |
|
489
UGI
UGI
$7.74B
| $15.6M | 0.04% |
314,896
+13,429
| +4% | +$638K |
|
|
AMTD
490
DELISTED
TD Ameritrade Holding Corp
AMTD
| $15.5M | 0.04% |
398,495
+74,862
| +23% | +$3.19M |
|
491
Toro Company
TTC
$8.75B
| $15.5M | 0.04% |
247,435
+33,677
| +16% | +$2.01M |
|
492
RPM International
RPM
$13.7B
| $15.4M | 0.04% |
280,218
+10,319
| +4% | +$550K |
|
493
Nasdaq
NDAQ
$52.7B
| $15.4M | 0.04% |
663,945
+30,105
| +5% | +$699K |
|
494
Willis Towers Watson
WTW
$31.7B
| $15.2M | 0.04% |
115,993
+3,670
| +3% | +$467K |
|
|
SBNY
495
DELISTED
Signature Bank
SBNY
| $15.1M | 0.04% |
101,612
+4,546
| +5% | +$704K |
|
496
IDEX
IEX
$17B
| $15.1M | 0.04% |
161,116
+6,844
| +4% | +$629K |
|
497
Atmos Energy
ATO
$28.8B
| $15M | 0.04% |
190,496
+8,913
| +5% | +$684K |
|
498
East-West Bancorp
EWBC
$17.9B
| $15M | 0.04% |
290,696
+427
| +0.1% | +$22.4K |
|
499
Reinsurance Group of America
RGA
$15.5B
| $15M | 0.04% |
118,149
+4,077
| +4% | +$517K |
|
|
WOOF
500
DELISTED
VCA Inc.
WOOF
| $15M | 0.04% |
163,529
+5,948
| +4% | +$534K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.